Janux Therapeutics (JANX) FCF Margin (2021 - 2026)
Janux Therapeutics (JANX) posted quarterly FCF Margin of 337.8% for Q1 2026, down 160.87% quarter-over-quarter from 129.49% in Q3 2025.
Powered by 
Analysis
Janux Therapeutics (JANX) FCF Margin (2021 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has reported FCF Margin for 6 consecutive years, with 337.8% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin changed N/A year-over-year to 337.8%; the TTM figure through Mar 2026 stood at 565.33% (down 7168.0% YoY), while the FY2025 annual figure was 819.59%, down 40224.0% from the prior year.
- FCF Margin slipped to 337.8% in Q1 2026 per JANX's latest filing, from 129.49% in the prior quarter.
- Across five years, FCF Margin topped out at 113.7% in Q2 2024 and bottomed at 1495.93% in Q2 2023.
- Historically, FCF Margin has averaged 577.74% across 5 years, with a median of 451.25% in 2024.
- Annual changes were most pronounced in 2022 — FCF Margin plunged 221398 bps — and 2024, when it jumped 138223 bps.
- Janux Therapeutics' FCF Margin stood at 429.74% in 2022, then gained by 2 bps to 423.24% in 2023, then fell by 7 bps to 451.25% in 2024, then soared by 71 bps to 129.49% in 2025, then sank by 161 bps to 337.8% in 2026.
- Business Quant data shows JANX's FCF Margin at 337.8% in Q1 2026, 129.49% in Q3 2025, and 451.25% in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -388.28% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 25.68% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 22.62% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 70.82% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 10 | Janux Therapeutics | 1.27 Bn | 1.27 Bn | - | 129.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 129.98% |
| Mar 31, 2026 | -366.27% |
| Sep 30, 2025 | -129.49% |
| Sep 30, 2024 | -513.90% |
| Jun 30, 2024 | -113.70% |
| Mar 31, 2024 | -1,200.80% |
| Dec 31, 2023 | -423.24% |
| Sep 30, 2023 | -476.80% |
| Jun 30, 2023 | -1,485.53% |
| Mar 31, 2023 | -698.54% |
| Dec 31, 2022 | -491.00% |
| Sep 30, 2022 | -878.87% |
| Jun 30, 2022 | -294.76% |
| Mar 31, 2022 | -786.22% |
| Dec 31, 2021 | -687.50% |
| Sep 30, 2021 | -558.67% |
| Jun 30, 2021 | -1,303.53% |
| Mar 31, 2021 | 1,423.68% |